Letrozole-d4 – 1 mg

Brand:
Cayman
CAS:
1133712-96-5
Storage:
-20
UN-No:
Non-Hazardous - /

Letrozole-d4 is intended for use as an internal standard for the quantification of letrozole (Item No. 11568) by GC- or LC-MS. Letrozole is a potent, cell-permeable inhibitor of aromatase (IC50 = 2 nM).{23490} It inhibits proliferation of estrogen receptor-positive (ER+) MCF-7 cells when used alone at concentrations ranging from 0.1 to 100 nM and when used at a concentration of 10 nM in combination with testosterone or 4-androstene-3,17-dione.{46076} It also reduces matrix metalloproteinase-2 (MMP-2) and MMP-9 levels in MCF-7 cells when used at a concentration of 10 nM. Letrozole (10 µg per day) reduces tumor growth in an MCF-7Ca ovariectomized-mouse xenograft model.{46077} Formulations containing letrozole have been used in the treatment of postmenopausal breast cancer.{23489}  

 

Available on backorder

SKU: 26517 - 1 mg Category:

Description

An internal standard for the quantification of letrozole by GC- or LC-MS


Formal name: 4-[(4-cyanophenyl)-1H-1,2,4-triazol-1-ylmethyl]-benzonitrile-2,3,5,6-d4

Synonyms: 

Molecular weight: 289.3

CAS: 1133712-96-5

Purity: ≥99% deuterated forms (d1-d4)

Formulation: A solid


Application|Mass Spectrometry||Product Type|Biochemicals|Analytical Standards||Product Type|Biochemicals|Isotopically Labeled Standards|Deuterium||Product Type|Biochemicals|Small Molecule Inhibitors|Sterol Biosynthesis||Research Area|Cancer||Research Area|Endocrinology & Metabolism|Hormones & Receptors|Androgens||Research Area|Endocrinology & Metabolism|Hormones & Receptors|Estrogens & Progestins